| scholarly article | Q13442814 |
| P50 | author | Stephen M Tompkins | Q59683451 |
| Elizabeth W. Howerth | Q118780161 | ||
| Ralph A. Tripp | Q45349521 | ||
| P2093 | author name string | Olivia Perwitasari | |
| Xiuzhen Yan | |||
| Sharon Shacham | |||
| Yosef Landesman | |||
| Scott Johnson | |||
| Dilara McCauley | |||
| Erkan Baloglu | |||
| Sharon Tamir | |||
| P2860 | cites work | Emerging roles for the influenza A virus nuclear export protein (NEP) | Q21089600 |
| THE HIV-1 REV PROTEIN | Q22241975 | ||
| A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection | Q24294658 | ||
| Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication | Q24309486 | ||
| Influenza B and C virus NEP (NS2) proteins possess nuclear export activities | Q24529536 | ||
| Structural basis for leucine-rich nuclear export signal recognition by CRM1 | Q24604395 | ||
| A national survey of severe influenza-associated complications among children and adults, 2003-2004. | Q48888940 | ||
| Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm | Q48964086 | ||
| Influenza | Q73495234 | ||
| Human host factors required for influenza virus replication | Q24629972 | ||
| The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus | Q24645420 | ||
| Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region | Q24685870 | ||
| Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens | Q26852062 | ||
| Nuclear export of proteins and drug resistance in cancer | Q27012444 | ||
| Acute respiratory distress syndrome induced by a swine 2009 H1N1 variant in mice | Q27310762 | ||
| CRM1-mediated Nuclear Export of Dengue Virus RNA Polymerase NS5 Modulates Interleukin-8 Induction and Virus Production | Q27488888 | ||
| Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells | Q27670981 | ||
| Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia | Q27674083 | ||
| Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1 | Q27675810 | ||
| Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade | Q27863694 | ||
| Inhibition of nuclear export of ribonucleoprotein complexes of influenza virus by leptomycin B. | Q27863701 | ||
| Assembly and budding of influenza virus | Q27863797 | ||
| An unconventional NLS is critical for the nuclear import of the influenza A virus nucleoprotein and ribonucleoprotein | Q27863807 | ||
| Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes | Q27864127 | ||
| Pneumonia in the elderly | Q28250486 | ||
| Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern | Q28275022 | ||
| MicroRNA regulation of human protease genes essential for influenza virus replication | Q28483683 | ||
| Influenza-associated hospitalizations in the United States | Q29619463 | ||
| Closely related influenza viruses induce contrasting respiratory tract immunopathology | Q30354070 | ||
| Drosophila RNAi screen identifies host genes important for influenza virus replication | Q30370530 | ||
| Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. | Q30384547 | ||
| Avian influenza virus isolates from wild birds replicate and cause disease in a mouse model of infection. | Q30385232 | ||
| Implication of inflammatory macrophages, nuclear receptors, and interferon regulatory factors in increased virulence of pandemic 2009 H1N1 influenza A virus after host adaptation | Q30416015 | ||
| An alternative direct compound dispensing method using the HP D300 digital dispenser | Q30440190 | ||
| Deaths: preliminary data for 2003. | Q30985378 | ||
| The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza | Q33423373 | ||
| Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation | Q34023297 | ||
| Coexistence of two adamantane binding sites in the influenza A M2 ion channel | Q34068392 | ||
| Characterization of the nuclear import and export functions of Ikappa B(epsilon). | Q34125004 | ||
| Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 | Q34129986 | ||
| Protein export from the nucleus | Q34384095 | ||
| A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export | Q34394284 | ||
| Neuraminidase inhibitors for influenza | Q34455162 | ||
| Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA | Q34629197 | ||
| Nucleocytoplasmic transport: cargo trafficking across the border | Q34688396 | ||
| Avian influenza virus isolation and propagation in chicken eggs | Q34764841 | ||
| A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes | Q34997917 | ||
| Seasonal influenza vaccines | Q35004203 | ||
| Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I study | Q35087639 | ||
| PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update | Q35631144 | ||
| Pathogenesis of respiratory syncytial virus infection | Q35848350 | ||
| Role of influenza vaccine for healthy children in the US. | Q35875663 | ||
| Phase I trial of elactocin | Q36135821 | ||
| Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia | Q36206410 | ||
| NESdb: a database of NES-containing CRM1 cargoes | Q36234505 | ||
| Short interfering RNA (siRNA): tool or therapeutic? | Q36334989 | ||
| Targeting organic anion transporter 3 with probenecid as a novel anti-influenza a virus strategy | Q36505517 | ||
| Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. | Q36551014 | ||
| Selective inhibitors of nuclear export block pancreatic cancer cell proliferation and reduce tumor growth in mice | Q36675242 | ||
| The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis | Q36955377 | ||
| Identification of nuclear export inhibitors with potent anticancer activity in vivo | Q37081966 | ||
| The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism | Q37191929 | ||
| Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein | Q37232839 | ||
| CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications. | Q37445828 | ||
| KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. | Q37693609 | ||
| Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma | Q39276952 | ||
| Cytoplasmic sequestration of rel proteins by IkappaBalpha requires CRM1-dependent nuclear export | Q39584943 | ||
| Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway | Q39601251 | ||
| Influenza: propagation, quantification, and storage | Q39943485 | ||
| Characterization of a CRM1-dependent nuclear export signal in the C terminus of herpes simplex virus type 1 tegument protein UL47. | Q39948859 | ||
| Nuclear import of the respiratory syncytial virus matrix protein is mediated by importin beta1 independent of importin alpha | Q40371587 | ||
| The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells | Q40433600 | ||
| Inhibition of IkappaBalpha nuclear export as an approach to abrogate nuclear factor-kappaB-dependent cancer cell survival. | Q40465497 | ||
| Importin alpha nuclear localization signal binding sites for STAT1, STAT2, and influenza A virus nucleoprotein | Q40648738 | ||
| Nuclear export of the human cytomegalovirus tegument protein pp65 requires cyclin-dependent kinase activity and the Crm1 exporter | Q41994064 | ||
| Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). | Q45152293 | ||
| Intracellular trafficking of influenza virus: clinical implications for molecular medicine | Q45672256 | ||
| A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins | Q45753472 | ||
| The unmet need in the elderly: designing new influenza vaccines for older adults | Q47793480 | ||
| P433 | issue | 17 | |
| P921 | main subject | influenza A virus | Q834390 |
| P304 | page(s) | 10228-10243 | |
| P577 | publication date | 2014-06-25 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo | |
| P478 | volume | 88 |
| Q28577939 | A Nuclear Attack on Traumatic Brain Injury: Sequestration of Cell Death in the Nucleus |
| Q38812797 | A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds |
| Q56996774 | Advancements in Host-Based Interventions for Influenza Treatment |
| Q38926249 | Anti-Influenza Treatment: Drugs Currently Used and Under Development |
| Q28554470 | Antiviral Efficacy of Verdinexor In Vivo in Two Animal Models of Influenza A Virus Infection |
| Q30391416 | Antivirals for Respiratory Viral Infections: Problems and Prospects |
| Q38519881 | Broad-spectrum antiviral agents |
| Q39431526 | CRM1 Inhibitors for Antiviral Therapy |
| Q28085400 | Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs |
| Q28084005 | Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus |
| Q59813350 | Controlling the Gatekeeper: Therapeutic Targeting of Nuclear Transport |
| Q34600066 | Cryptoporus volvatus extract inhibits influenza virus replication in vitro and in vivo |
| Q55039331 | Host-directed combinatorial RNAi improves inhibition of diverse strains of influenza A virus in human respiratory epithelial cells. |
| Q40506281 | Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana). |
| Q45323947 | Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein |
| Q90681995 | Impact of Respiratory Syncytial Virus Infection on the Host Cell: Implications for Antiviral Strategies |
| Q57454827 | In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals |
| Q38708072 | Inhibition of CRM1-mediated nuclear export of influenza A nucleoprotein and nuclear export protein as a novel target for antiviral drug development |
| Q30375026 | Interplay between influenza A virus and host factors: targets for antiviral intervention. |
| Q47886776 | Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses |
| Q37203156 | NXT1, a Novel Influenza A NP Binding Protein, Promotes the Nuclear Export of NP via a CRM1-Dependent Pathway |
| Q30249294 | Nipah virus matrix protein: expert hacker of cellular machines. |
| Q112286875 | Nuclear-localized human respiratory syncytial virus NS1 protein modulates host gene transcription |
| Q100384122 | Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review |
| Q30234943 | Progress of small molecular inhibitors in the development of anti-influenza virus agents |
| Q64082340 | RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals |
| Q47555181 | Regulation of influenza virus replication by Wnt/β-catenin signaling |
| Q26796151 | Respiratory virus modulation of host nucleocytoplasmic transport; target for therapeutic intervention? |
| Q39393272 | Role of Host Genes in Influenza Virus Replication |
| Q107329242 | Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo |
| Q104795052 | Targeting XPO1 enhances innate immune response and inhibits KSHV lytic replication during primary infection by nuclear stabilization of the p62 autophagy adaptor protein |
| Q37739368 | Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment |
| Q28071809 | The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design |
| Q90434268 | Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication In Vitro |
| Q47549703 | Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses |
| Q66679726 | Viral Appropriation: Laying Claim to Host Nuclear Transport Machinery |
Search more.